Promoted Content
Promoted Content

Company profile for Minakem

Client EmailClient Virtual Booth
MINAKEM
  • Connect with Us...

  • Corporate Presentation

  • Challenging Chemistry in Pharmaceutical Manufacturing

  • Building Blocks and GMP Excipients 2020

  • API Product Portfolio 2020

  • 1,1-Cyclobutane Dicarboxylic Acid

  • Budesonide

  • Cyclobutane Carboxaldehyde

  • Cyclopropyl Methyl Bromide

  • Cyclopropyl Methyl Chloride

  • Esomeprazole Magnesium

  • Esomeprazole Sodium

  • Esomeprazole Strontium

  • Propyl Gallate

  • Vinblastine Sulfate

  • Vincristine Sulfate

  • Vinorelbine Tartrate

  • All Services

  • API Manufacturing

  • API & Drug Product Development

  • Continuous Flow Chemistry

  • Fine Chemical / Intermediate Development

  • Clinical Supply

  • Particle Size Reduction & Micronization

  • Polymorph & Cocrystal Study

  • Development of High Potency APIs (HPAPIs)

PharmaCompass

Virtual Booth CDMO (API & HPAPI)/ Generics/ Security of supply/ Regulatory submission expertise/ Track record performance/ FDA & GMP

With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and biotechnological companies to develop and provide innovative treatments of the highest quality to their patients globally. We have a proven track record in our capability to take projects from early stage through to commercial production. We operate three FDA inspected sites in France and Belgium.
Minakem-RM
Minakem
France Flag
Country
Country
FRANCE
Address
Address
224 Avenue de la Dordogne, 59640 Dunkerque
Telephone
Telephone
+33 3 20 64 68 30
Contact Info
Others

left grey arrow
right gray arrow
  • Corporate Presentation
  • Challenging Chemistry in Pharmaceutical Manufacturing
  • Building Blocks and GMP Excipients 2020
  • API Product Portfolio 2020

https://www.pharmacompass.com/pdf/party/content/minakem-party-content-1601297404.pdf

https://www.pharmacompass.com/pdf/party/content/minakem-party-content-1608700748.pdf

https://www.pharmacompass.com/pdf/party/content/minakem-party-content-1604661963.pdf

https://www.pharmacompass.com/pdf/party/content/minakem-party-content-1601298776.pdf

INSPECTIONS & REGISTRATIONS

Contact the Supplier
Voluntary Action Indicated
2010-07-08
Beuvry La Foret
FR
ORA
CDER
Drug Quality Assurance

INSPECTIONS & REGISTRATIONS

Contact the Supplier
Voluntary Action Indicated
2010-07-08
Beuvry La Foret
FR
ORA
CVM
Monitoring of Marketed An...

INSPECTIONS & REGISTRATIONS

Contact the Supplier
Voluntary Action Indicated
2013-09-13
Beuvry La Foret
FR
ORA
CDER
Drug Quality Assurance

INSPECTIONS & REGISTRATIONS

Contact the Supplier
Voluntary Action Indicated
2013-09-13
Beuvry La Foret
FR
ORA
CVM
Monitoring of Marketed An...

INSPECTIONS & REGISTRATIONS

Contact the Supplier
No Action Indicated
2015-09-24
Corbais
BE
ORA
CDER
Drug Quality Assurance

INSPECTIONS & REGISTRATIONS

Contact the Supplier
Voluntary Action Indicated
2012-01-12
Corbais
BE
ORA
CDER
Drug Quality Assurance

INSPECTIONS & REGISTRATIONS

Contact the Supplier
No Action Indicated
2014-06-13
Leuna
DE
ORA
CDER
Drug Quality Assurance

INSPECTIONS & REGISTRATIONS

Contact the Supplier
No Action Indicated
2013-05-17
Dunkirk
FR
ORA
CDER
Drug Quality Assurance

INSPECTIONS & REGISTRATIONS

Contact the Supplier
No Action Indicated
2011-07-07
Leuna
DE
ORA
CDER
Drug Quality Assurance

INSPECTIONS & REGISTRATIONS

Contact the Supplier
Voluntary Action Indicated
2016-03-25
Beuvry la Foret
FR
ORA
CDER
Drug Quality Assurance
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty